Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
20 hedge funds and large institutions have $63.8K invested in Coeptis Therapeutics Warrants in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
12% more capital invested
Capital invested by funds: $56.9K → $63.8K (+$6.97K)
6.41% more ownership
Funds ownership: 0% → 6.41% (+6.4%)
5% more funds holding
Funds holding: 19 → 20 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$43K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$469 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$4 |
| 4 |
CS
Clear Street
New York
|
+$4 |
| 5 |
CAC
Cowen and Company
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$17.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$459 |
| 3 |
CG
Cutler Group
San Francisco,
California
|
-$103 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$12 |
COEPW Hedge Fund Activity: Q1 2024 in Review
20 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2024, worth a combined $63.8K — up 12% from $56.9K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new COEPW positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Meteora Capital, adding an estimated $43K. The largest seller was Ionic Capital Management, cutting an estimated $17.4K.
- 20 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2024, up from 19 in Q4 2023.
- Funds reported $63.8K of Coeptis Therapeutics Warrants stock for Q1 2024, up 12% quarter-over-quarter.
- 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest Coeptis Therapeutics Warrants buyer in Q1 2024 was Meteora Capital, an estimated $43K added.
- The largest Coeptis Therapeutics Warrants seller in Q1 2024 was Ionic Capital Management, an estimated $17.4K sold.
Based on aggregated 13F filings for Q1 2024.